|

货币单位:美元(USD)

Immune Design Corp. (imdz)

实时(?):

盘后(?):

读取中...

-- (--%)

开盘价:--	最高价:--	最低价:--	52周最高价:--	52周最低价:--
成交量:--	平均成交量:--	市值:--	市盈率:--	预期市盈率:--
每股收益:--	贝塔系数:--	股息:--	收益率:--	总股本:--

提示:交易结束

Rita A. Karachun	Rita A. Karachun currently works at Immune Design Corp., as Chief Executive Officer & Director, Prometheus Biosciences, Inc., as Chief Executive Officer & Director from 2023, Harrisvaccines LLC, as President & Director, GlycoFi, Inc., as President & Director, Imago BioSciences, Inc., as President & Director, Jersey Battered Women's Service, Inc., as Director from 2016, and Coherus Oncology, Inc., as Independent Director from 2024. Ms. Karachun also formerly worked at Organon & Co., as Director, Acceleron Pharma, Inc., as President & Director, ArQule, Inc., as President & Director, Merck & Co., Inc., as Senior Vice President-Finance & Global Controller from 2014 to 2023, Inspire Pharmaceuticals, Inc., as President, and AT&T Corp., as Chief Accountant & Assistant Controller from 1996 to 2006. Ms. Karachun received her undergraduate degree from Fairleigh Dickinson University.
Caroline A. Litchfield	Ms. Caroline A. Litchfield is an Independent Director at Verizon Communications, Inc., a Chief Financial Officer & Director at Immune Design Corp. and a Chief Financial Officer & Executive Vice President at Merck & Co., Inc. She is on the Board of Directors at Verizon Communications, Inc. and Immune Design Corp. Ms. Litchfield was previously employed as a Finance Director by Merck Sharp & Dohme Ltd. She also served on the board at Fulford (India) Ltd. and Organon & Co. She received her undergraduate degree from the University of Leicester.

Rita A. Karachun

Rita A. Karachun currently works at Immune Design Corp., as Chief Executive Officer & Director, Prometheus Biosciences, Inc., as Chief Executive Officer & Director from 2023, Harrisvaccines LLC, as President & Director, GlycoFi, Inc., as President & Director, Imago BioSciences, Inc., as President & Director, Jersey Battered Women's Service, Inc., as Director from 2016, and Coherus Oncology, Inc., as Independent Director from 2024. Ms. Karachun also formerly worked at Organon & Co., as Director, Acceleron Pharma, Inc., as President & Director, ArQule, Inc., as President & Director, Merck & Co., Inc., as Senior Vice President-Finance & Global Controller from 2014 to 2023, Inspire Pharmaceuticals, Inc., as President, and AT&T Corp., as Chief Accountant & Assistant Controller from 1996 to 2006. Ms. Karachun received her undergraduate degree from Fairleigh Dickinson University.

Caroline A. Litchfield

Ms. Caroline A. Litchfield is an Independent Director at Verizon Communications, Inc., a Chief Financial Officer & Director at Immune Design Corp. and a Chief Financial Officer & Executive Vice President at Merck & Co., Inc. She is on the Board of Directors at Verizon Communications, Inc. and Immune Design Corp. Ms. Litchfield was previously employed as a Finance Director by Merck Sharp & Dohme Ltd. She also served on the board at Fulford (India) Ltd. and Organon & Co. She received her undergraduate degree from the University of Leicester.